Podcasts about mckesson

Join host Dr. Britney Woods, PharmD, Senior Manager on the McKesson Health Mart team, for a special Know Before You Go episode created to help independent pharmacy owners get real value from McKesson ideaShare 2026 - before they even arrive. Featuring Jaime Montuoro, PharmD, Director of Education and Practice Advancement with McKesson/Health Mart, Alanna Douglas, Senior Marketing Manager on the McKesson/Health Mart team, this conversation goes behind the scenes of how ideaShare is intentionally designed for today's independent pharmacies. Tune in to hear what education themes matter most this year, how to build a schedule that balances inspiration with practical implementation, and the inspiration behind the Health Mart Pharmacy of the Year award. Whether it's your first ideaShare or your tenth, this episode will help you show up with a plan and leave ready to put ideas into action back at your pharmacy. HostBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartGuestsJaime Montuoro, PharmDDirector of Education & Practice Advancement McKesson/Health MartAlanna DouglasSr. Marketing Manager McKessonResourcesTune into Episode 23: Community Roots to Clinical Impact – Inside a Pharmacy of the Year Winner featuring Dave Randolph and Mikayla Smith, last year's Health Mart Pharmacy of the Year winners. In this episode, they discuss how they expanded clinical services, fostered staff development, and implemented sustainable solutions for patient care while serving their rural community. Health Mart Pharmacies can access Health Mart University (HMU) to: Enroll in the Independent Insights Podcast Package to conveniently access new monthly podcast episodes and claim continuing education (CE) credit (pharmacists) for weekly GameChangers clinical episodes. Access hundreds of no-cost continuing education courses to help elevate pharmacy staff knowledge and maintain state licensure requirements  ReferencesGo to mckessonideashare.com to learn more and registered attendees can login to the Attendee Hub to start planning your McKesson ideaShare 2026 now.  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In der heutigen Folge sprechen die Finanzjournalisten Daniel Eckert und Lea Oetjen über die neue KI-Offensive von Alphabet, robuste Zeiten für die Baumärkte und das Milliarden-Projekt von OHB. Außerdem geht es um Nvidia, Qualcomm, Amazon, Broadcom, Micron, Arm, Intel, Home Depot, Hornbach Holding, Ottobock, EQT, Uniper, Rheinmetall, SAP, Nemetschek, Atoss Software, Infineon, SMA Solar, Ströer, Eli Lilly, Novo Nordisk, Mondelēz International, Domino's Pizza, McKesson, Cencora, Cardinal Health, Vanguard FTSE All-World UCITS ETF (WKN: A1JX52), JPMorgan EUR Corporate Bond Research Enhanced Index UCITS ETF (WKN: A2N76D), Vanguard EUR Corporate Bond UCITS ETF (WKN: A143JK), VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF (WKN: A2JAHJ) und Amundi Smart Overnight Return UCITS ETF (WKN: LYX0WM). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Hier könnt ihr den AAA-Newsletter abonnieren: https://www.welt.de/newsletter/article232797673/Alles-auf-Aktien-Der-taegliche-Boersen-Newsletter-fuer-WELTplus-Abonnenten.html Und - ganz neu: AAA gibt es jetzt auch auf Instagram: https://www.instagram.com/alles_auf_aktien/ Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Kansas City's industrial market has seen a meaningful share of new deliveries translate directly into occupancy, with build-to-suit activity playing an outsized role in recent absorption.In the third episode of Inside Industrial, JLL's Kevin Wilkerson and Phil Algrim joined CPE's Diana Firtea to discuss how disciplined development, competition for sites and power availability are influencing Kansas City's next phase of industrial growth.Wilkerson pointed to a string of large build-to-suit deliveries completed over the last 12 to 18 months, including projects for Ace, Amazon, Church & Dwight, Blue Buffalo, McKesson and Pimco Bakeries.The guests also noted that speculative development has remained disciplined, with a limited pool of active developers and rising competition for development-ready land. They described how data center demand has pushed some land pricing above levels that industrial projects can underwrite, adding another variable for developers trying to pencil new starts.On feasibility, they cited Kansas City's strong electrical grid for traditional industrial uses, but said power constraints become more complex for manufacturing and data center projects, where Evergy's energy study process can add meaningful cost and time early in site selection.

Join host Dr. Britney Woods, PharmD, Sr. Manager of Community Pharmacy at McKesson Health Mart, for a compelling conversation about the power of automation in independent pharmacies. This episode features special guests Faisal Adam, Pharmacist at Mark's Pharmacy, and Alisha Nanji, Pharmacy Manager with McKesson Canada, who share their firsthand experiences on how thoughtfully implemented automation can help transform daily operations, ease the workload for pharmacy teams, and elevate patient care. Listen in as they explore practical strategies for unlocking real capacity and efficiency in the pharmacy setting and discover how embracing technology can help make a meaningful difference for both your staff and patients.HostBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartGuestsFaisal Adam, PharmDPharmacistMark's PharmacyAlisha Nanji, HBSc, BSc Phm, RPh, (ON/NB)Pharmacy ManagerMcKesson CanadaResourcesYou can learn more about McKesson Pharmacy Automation Services here: https://www.mckesson.com/automation/ ReferencesHealth Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE courses and more on inventory management and workflowHealth Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Train With Duane!This week on Geek Off The Street, we're with our friend Chris again to talk about Jujutsu Kaisen Season 3! We get into all things like the depth to the story and characters but we also discuss whether or not the animation holds up from the last season! All that and so much more on this week's exciting episode of the GOTS Official Podcast!Podcast Timecodes[4:30] What are we drinking this week?[11:00] Opening Thoughts[12:30] Positives[1:07:25] Negatives[1:46:55] What Are We Into This Week?Check Out These Books!When The Frog and the Snake Meet: A Killing Love! by J. Leroy Tucker!Wilbur  Mckesson's Retribution!Greg Sorber's Mechhaven! Pax Machina Audio Book!Join Us in the Discussion!Email: thegeeksoffthestreet@gmail.comInstagram: @thegotspodSubscribe on Youtube! Like Our Facebook! Twitter: @thegotspodTrent Personal: @trentctuckerMusic: @erictucker__Stuff We MentionedChikara Ramen!Trent Tucker Vlogs!Invincible!Maul Shadow Lord!People We MentionedTree of Dreams Music@chikara_ramen@badicalradness@lights.camera.rant@thenerdlounge2.0@gregerationx@author_wilbur_m@mcpodcast@z_daughter_of_light@mindmattermystery

AI is moving fast, and for a lot of leaders that creates both pressure and possibility. In this episode of Leader Generation, Tessa Burg talks with Rohit Prabhakar, Global Head of Digital Experiences and Capabilities at Visa, about what it really takes to lead transformation when the rules keep changing. They dig into why strong foundations still matter, why connected data is more important than ever and why leaders need to balance quick wins with bigger reimagining. If you're trying to make sense of AI beyond the hype, this conversation is worth your time. Rohit shares practical ways to think about adoption, experimentation and change management without getting stuck in overplanning or unrealistic ROI expectations. It's a thoughtful listen for anyone leading teams, modernizing operations or figuring out how to move forward while bringing people along with them. Leader Generation is hosted by Tessa Burg and brought to you by Mod Op. About Rohit Prabhakar: Rohit Prabhakar is a Fortune 50 CMO and Chief Digital Officer who has generated $1.7B+ in business value by turning customer obsession into revenue growth. Currently leading global digital experiences at Visa, he has transformed marketing, data, AI, and CX across McKesson, Thomson Reuters, and FIS. Rohit's superpower: making customers love the most powerful growth engine. You can reach him at Rohitprabharkar.com or on LinkedIn. About Tessa Burg: Tessa is the Chief Technology Officer at Mod Op and Host of the Leader Generation podcast. She has led both technology and marketing teams for 15+ years. Tessa initiated and now leads Mod Op's AI/ML Pilot Team, AI Council and Innovation Pipeline. She started her career in IT and development before following her love for data and strategy into digital marketing. Tessa has held roles on both the consulting and client sides of the business for domestic and international brands, including American Greetings, Amazon, Nestlé, Anlene, Moen and many more. Tessa can be reached on LinkedIn or at Tessa.Burg@ModOp.com.  

In der heutigen Folge sprechen die Finanzjournalisten Lea Oetjen und Holger Zschäpitz über den nächsten Taco-Trade, den Absturz der Tech-Titel und die Gewinne von CTS Eventim. Außerdem geht es um AMD, Intel, Nvidia, Micron, Lam Research, ASML, Meta, Alphabet, APA Corporation, Occidental Petroleum, EOG Resources, Valero Energy, Autodesk, Salesforce, CrowdStrike, Fortinet, Netflix, Olaplex Holdings, Henkel, TUI, Siemens Energy, Deutz, Carnival, Wüstenrot & Württembergisch, Jungheinrich, SAP, Deutsche Post, Siemens, Apollo, Blackstone, KKR, SK Hynix, Commerzbank, Apple, Mondelez International, McKesson, Loews, Morgan Stanley, Wells Fargo, Visa, Mastercard, American Express, JPMorgan Chase, Bank of America, Citigroup, General Dynamics und RTX. Hier kostenlos für den AAA-Newsletter anmelden: https://www.businessinsider.de/informationen/newsletter/alles-auf-aktien/ Wir freuen uns an Feedback über aaa@welt.de. Noch mehr „Alles auf Aktien“ findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Hier könnt ihr den AAA-Newsletter abonnieren: https://www.welt.de/newsletter/article232797673/Alles-auf-Aktien-Der-taegliche-Boersen-Newsletter-fuer-WELTplus-Abonnenten.html Und - ganz neu: AAA gibt es jetzt auch auf Instagram: https://www.instagram.com/alles_auf_aktien/ Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast „Deffner&Zschäpitz“ hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

What does it look like to build a pharmacy that not only survives—but thrives?In this episode of Independent Insights, host Britney Woods talks with Dave Randolph, owner of Dave's Pharmacy, and Mikayla Smith, pharmacy manager, about their journey as an independent pharmacy serving rural communities. Together, these Health Mart Pharmacy of the Year award winners discuss expanding clinical services, supporting staff through growth, and finding sustainable ways to meet patient needs when access to care is limited.Through candid stories and practical lessons, this episode highlights how thoughtful advocacy, innovation, and leadership can help strengthen both patient care and the longterm health of an independent pharmacy. HostBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartGuestsDave Randolph, RPhPharmacy OwnerDave's PharmacyMikayla Smith, CPhTAA Business Pharmacy ManagerDave's PharmacyReferencesTune into these additional Independent Insights episodes for more details on ECAPs and hosting a legislator mentioned during this podcast episode:Episode 19: Your Pharmacy, Your Voice: Why HR3164 (ECAPS) Needs YouEpisode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Why Collaboration Is the Key to Employer Brand Activation, with Haley de la Grana of McKesson by Jorgen Sundberg

In this episode of Tank Talks, Matt Cohen sits down with Ali Asaria, Co-Founder of Transformer Lab, to unpack the less visible side of the AI boom, from broken machine learning tools to the rise of autonomous research agents. Ali shares what it really looks like inside modern AI development and why the biggest opportunity isn't just using models, but having the ability to train, control, and improve them.Ali also reflects on his journey building across multiple tech waves, from creating BrickBreaker on BlackBerry to scaling Well.ca and Tulip, and now tackling AI infrastructure with Transformer Lab. He breaks down the realities most founders don't talk about, why great products lose deals, how long enterprise sales actually take, and why success often comes down to trust, timing, and people more than technology.Beyond AI, the conversation takes a broader turn into the future of innovation. Ali challenges the tech industry, especially in Canada, to think bigger, rebuild public trust, and focus on solving real-world problems through ambitious “mega projects.” If you're trying to separate AI hype from reality and understand where the real leverage is being created, this episode gives you a much clearer lens.Building BrickBreaker on 150M Devices (00:02:41)How a side project at BlackBerry turned into a global phenomenon. The early lesson that distribution beats perfection. Ali shares how building something simple but widely adopted gave him an early taste of scale. It also shaped his belief that getting into users' hands fast matters more than polishing endlessly in isolation.The Early Days of E-Commerce in Canada (00:05:36)Packing boxes manually, hacking payment systems, and why investors believed e-commerce would never work in Canada. From manually processing credit cards to building infrastructure from scratch, Ali walks through how scrappy the early days really were. It's a reminder that many “obvious” markets today once looked completely unworkable.Scaling Well.ca and the McKesson Exit (00:08:18)How relationships with partners turned into acquisition opportunities. The messy reality behind “successful exits.” Ali explains how long-term partnerships quietly set the stage for acquisition, even before it was intentional. He also highlights how unpredictable and fragile deals can be, even when they seem done.Enterprise Sales Lessons from Tulip (00:11:19)Why great products don't win deals. Trust, relationships, and the human side of multi-million dollar contracts. Ali breaks down how enterprise sales are less about features and more about credibility and relationships built over time. He also shares how incumbents win not because they're better, but because they're already embedded.The Hard Truth About Startup Life (00:13:52)“90% hell, 10% fun.” What founders don't talk about publicly and how to choose the right investors. Behind the highlight reels, Ali emphasizes how difficult the journey really is and how rarely things go to plan. Choosing the right partners becomes critical when things inevitably get hard.The Moment AI Changed Everything (00:16:22)Why language models shattered the belief that human intelligence couldn't be replicated. Ali describes the exact moment his worldview shifted after seeing what LLMs could do. What once felt impossible suddenly became inevitable, changing how he thought about both technology and opportunity.What Transformer Lab Actually Does (00:20:11)Simplifying AI model training, orchestration, and infrastructure across local machines and massive GPU clusters. Ali explains how fragmented and complex current AI workflows are, especially for researchers. Transformer Lab aims to remove that friction and make building models far more accessible and efficient.Scaling AI From One Machine to Thousands (00:23:14)The technical leap required to move from hobbyist experimentation to full-scale AI labs. Moving from a single machine to distributed systems introduces massive complexity most developers never see. Ali breaks down why solving this unlock is essential for the next generation of AI builders.AI Hype vs Reality (00:25:41)Why Ali believes we may already have AGI, and why valuations still don't make sense. Ali challenges the common narrative by arguing we're closer to AGI than people admit. At the same time, he questions whether the current market can realistically justify the valuations we're seeing.Canada's Startup Ecosystem: Challenges & Advantages (00:32:11)Why geography matters less than mindset, and why building is always hard everywhere. Ali pushes back on the idea that location is the primary constraint for founders. Instead, he argues that resilience and ambition matter far more than where you're building from.Why Tech Has Lost Public Trust (00:34:12)From rebels to power players, and what founders must do to rebuild credibility. Ali reflects on how the tech industry's image has shifted over time and why that matters. Rebuilding trust requires focusing on real impact, not just growth or financial wins.The Case for Mega Projects (00:38:09)Why Canada needs bold, visible innovation bets that actually improve everyday life. Ali argues that large-scale, collaborative initiatives could realign public perception and drive meaningful progress. The key is solving problems people actually feel in their daily lives.The Future of AI and Talent Sovereignty (00:41:28)Why owning talent matters more than owning infrastructure in the AI race. Ali emphasizes that long-term advantage comes from people, not just technology or compute. Countries that develop and retain top talent will ultimately shape the future of AI.About Ali AsariaAli Asaria is a serial entrepreneur and one of Canada's most accomplished technology founders. He created the iconic BrickBreaker game on BlackBerry, founded Well.ca (later acquired by McKesson), and built Tulip into a leading enterprise retail platform backed by top-tier investors.He is now the co-founder of Transformer Lab, an open-source platform designed to simplify and scale AI model development. His work focuses on democratizing access to AI infrastructure, enabling developers and organizations to build advanced models without the complexity traditionally required.Ali is known for his bold thinking on AI, startup ecosystems, and the future of technology, often challenging conventional narratives around innovation and scale.Connect with Ali Asaria on LinkedIn: https://www.linkedin.com/in/aliasaria/Visit the Transformer Lab website: https://lab.cloud/Connect with Matt Cohen on LinkedIn: https://ca.linkedin.com/in/matt-cohen1Visit the Ripple Ventures website: https://www.rippleventures.com/ This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit tanktalks.substack.com

In episode 244, Coffey talks with Dr. Jason Jones about how leaders must adapt their thinking and behavior to navigate the rapid disruption caused by artificial intelligence.  They discuss why AI represents a step-change disruption compared to past technology waves; growing workforce resistance and fear surrounding AI adoption in organizations; how enterprise AI systems will soon integrate SOPs, training, and operational knowledge; the neuroscience behind fear, uncertainty, and cognitive rigidity during change; why leaders must develop cognitive adaptability and emotional regulation; the concept of neuro-adaptive leadership and upgrading the brain's operating system; attuning to disruption through proactive awareness and disruption scanning; decoding thought patterns and identifying hidden biases that block innovation; aligning leadership identity with values to guide behavior under pressure; using reflection, reframing, and replacement to rewire thinking through neuroplasticity; and how leaders can model adaptive thinking to help teams thrive during uncertainty.  For HR teams who discuss this podcast in their team meetings, we've created a discussion starter PDF to help guide your conversation. Download it here https://goodmorninghr.com/EP244  Good Morning, HR is brought to you by Imperative—Bulletproof Background Checks. For more information about our commitment to quality and excellent customer service, visit us at https://imperativeinfo.com.   If you are an HRCI or SHRM-certified professional, this episode of Good Morning, HR has been pre-approved for half a recertification credit. To obtain the recertification information for this episode, visit https://goodmorninghr.com.   About our Guest:  Dr. Jones equips leaders and teams with science-based strategies to activate peak performance, drive engagement, and thrive in the age of disruption. He is a leading authority on NeuroAdaptive Leadership™ and the neuroscience of performance, helping organizations rewire the way their leaders think, act, and inspire others. Dr. Jones is an Organizational Psychologist, executive coach, and international keynote speaker.   Drawing from cutting-edge neuroscience and more than 150 years of motivation and performance research, Dr. Jones has developed a practical and engaging approach to leadership that helps people understand and optimize how the brain drives behavior, influence, and decision-making. His approach has been used by Fortune 500 companies and forward-thinking organizations around the world, helping empower leaders to bring out the best in themselves and those they lead.  As the founder and CEO of LeaderPath, Dr. Jones has worked with some of the world's most recognized brands, including Microsoft, IBM, Porsche, AT&T, American Airlines, McKesson, Seagate Technology, and the Dallas Cowboys. His work has been featured by Inc. Magazine, FOX, CBS, ABC, and PBS, and his thought leadership continues to shape how modern leaders adapt, connect, and perform in an ever-changing world.  He is the two-time best-selling author of "Activator: Using Brain Science to Boost Motivation, Deepen Engagement, and Supercharge Performance" and "28 Days to a Motivated Team."   Prior to founding LeaderPath, Dr. Jones led executive education at AT&T, where he was responsible for developing more than 6,000 leaders globally, contributing to AT&T being named the #1 Learning Organization in America by Chief Learning Officer Magazine.  Outside of his work, Jason enjoys traveling, outdoor adventures, spending time with his grown children, and fueling his passion for helping others live and lead with purpose, resilience, and flow.  Dr. Jason Jones can be reached at https://drjasonjones.com  https://www.linkedin.com/in/DrJasonJones1  https://www.instagram.com/drjjones  https://www.youtube.com/c/DrJasonJones1   About Mike Coffey:  Mike Coffey is an entrepreneur, licensed private investigator, business strategist, HR consultant, and registered yoga teacher. In 1999, he founded Imperative, a background investigations and due diligence firm helping risk-averse clients make well-informed decisions about the people they involve in their business. Imperative delivers in-depth employment background investigations, know-your-customer and anti-money laundering compliance, and due diligence investigations to more than 300 risk-averse corporate clients across the US, and, through its PFC Caregiver & Household Screening brand, many more private estates, family offices, and personal service agencies. Imperative has been named a Best Places to Work, the Texas Association of Business' small business of the year, and is accredited by the Professional Background Screening Association.  Mike shares his insight from 25+ years of HR-entrepreneurship on the Good Morning, HR podcast, where each week he talks to business leaders about bringing people together to create value for customers, shareholders, and community. Mike has been recognized as an Entrepreneur of Excellence by FW, Inc. and has twice been recognized as the North Texas HR Professional of the Year.  Mike serves as a board member of a number of organizations, including the Texas State Council, where he serves Texas' 31 SHRM chapters as State Director-Elect; Workforce Solutions for Tarrant County; the Texas Association of Business; and the Fort Worth Chamber of Commerce, where he is chair of the Talent Committee. Mike is a certified Senior Professional in Human Resources (SPHR) through the HR Certification Institute and a SHRM Senior Certified Professional (SHRM-SCP). He is also a Yoga Alliance registered yoga teacher (RYT-200) and teaches multiple times each week. Mike and his very patient wife of 28 years are empty nesters in Fort Worth.  Learning Objectives: Understand why AI disruption is fundamentally different from previous technology shifts in the workplace. Recognize cognitive rigidity and emotional responses that block effective adaptation to change. Apply neuro-adaptive leadership techniques to help teams respond productively to rapid disruption. 

What does it take to make billion-dollar decisions inside one of the most powerful companies in the world? In this episode of The 30 Minute Hour, we go inside the mind of former Google finance leader Lamont Johnson. From shaping financial strategy at global giants like Google, Coca-Cola, and McKesson to leading with purpose beyond the numbers, Lamont shares powerful insights on leadership, decision-making, mentorship, and why impacting lives is the real key to impacting the bottom line. This conversation will challenge how you think about success, leadership, and legacy! #LeadershipMindset#BusinessLeadership#GoogleLeadership#ExecutiveMindset#The30MinuteHour

In this episode of #TheShot of #DigitalHealth Therapy, Jim Joyce and I sit down with Carl Bradford Byers

A familiar format, a subtle shift, and something worth sticking around for. This episode includes an introduction to the next chapter of Independent Insights. HostSuzanne Feeney, PharmDSr. Director, Pharmacy SolutionsMcKesson / Health MartGuestsBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartThe views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

"Why are we paying $10,000 for a $30 drug?"My guest this week is Pramod John, a former Silicon Valley tech entrepreneur who entered the healthcare space to tackle the largest economic problem in the country: skyrocketing healthcare costs. Pramod quickly realized that healthcare's dysfunction is actually not a technology problem - it is a deeply ingrained problem with economic incentives.In this episode, we dive into the murky waters of Pharmacy Benefit Managers (PBMs) and why the traditional model is designed to drive up costs rather than lower them. We discuss the shocking statistics of drug spend (where 2% of people account for 55% of the costs), why FDA approval doesn't always mean a drug is effective (using the infamous Alzheimer's drug as an example), and the implications of recent fiduciary lawsuits like the one against J&J.Pramod explains how we can bring common sense back to healthcare by treating drugs like any other consumer purchase. By utilizing an "open market" drug management model, he argues that we can effectively replace traditional PBMs with transparent transaction processing software - saving plans 30% to 50% without relying on restrictive formularies or rebate games. Tune in this week for a clear roadmap for how to actually fix the irrational economics of our healthcare system.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit ParetoHealth.com to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Why We Talk About Cost Instead of Quality (00:02:42) From Silicon Valley & Defense Tech to McKesson (00:10:43) Why Healthcare is NOT a Technology Problem (00:15:53) Fiduciary Responsibility & The J&J Lawsuit (00:19:03) The Butter Knife vs. Pareto: The Math of Drug Spend (00:23:54) Building an "Open Market" Alternative to PBMs (00:29:40) Why Doctors Fly Blind on Drug Pricing & Formularies (00:35:42) FDA Approval vs. Real-World Efficacy (00:45:44) How to Actually Fix the Model: The Real-Time "Pause" (00:58:36) Why International Sourcing & PAPs Aren't the Fix (01:11:00) Replacing PBMs with Simple Transaction SoftwareKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

"Why are we paying $10,000 for a $30 drug?"My guest this week is Pramod John, a former Silicon Valley tech entrepreneur who entered the healthcare space to tackle the largest economic problem in the country: skyrocketing healthcare costs. Pramod quickly realized that healthcare's dysfunction is actually not a technology problem - it is a deeply ingrained problem with economic incentives.In this episode, we dive into the murky waters of Pharmacy Benefit Managers (PBMs) and why the traditional model is designed to drive up costs rather than lower them. We discuss the shocking statistics of drug spend (where 2% of people account for 55% of the costs), why FDA approval doesn't always mean a drug is effective (using the infamous Alzheimer's drug as an example), and the implications of recent fiduciary lawsuits like the one against J&J.Pramod explains how we can bring common sense back to healthcare by treating drugs like any other consumer purchase. By utilizing an "open market" drug management model, he argues that we can effectively replace traditional PBMs with transparent transaction processing software - saving plans 30% to 50% without relying on restrictive formularies or rebate games. Tune in this week for a clear roadmap for how to actually fix the irrational economics of our healthcare system.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit ParetoHealth.com to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Why We Talk About Cost Instead of Quality (00:02:42) From Silicon Valley & Defense Tech to McKesson (00:10:43) Why Healthcare is NOT a Technology Problem (00:15:53) Fiduciary Responsibility & The J&J Lawsuit (00:19:03) The Butter Knife vs. Pareto: The Math of Drug Spend (00:23:54) Building an "Open Market" Alternative to PBMs (00:29:40) Why Doctors Fly Blind on Drug Pricing & Formularies (00:35:42) FDA Approval vs. Real-World Efficacy (00:45:44) How to Actually Fix the Model: The Real-Time "Pause" (00:58:36) Why International Sourcing & PAPs Aren't the Fix (01:11:00) Replacing PBMs with Simple Transaction SoftwareKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

AI is revolutionizing how health information is managed. Utilizing sophisticated algorithms, it can assist professionals in making more informed decisions. For instance, optical character recognition (OCR) can read and interpret medical records, identifying potential compliance issues and ensuring every page represents the correct patient.  In this episode, host Sandy Vance chats with Anupriyo Chakravarti, the Chief Technology and Product Officer at Verisma, about how healthcare organizations can use intelligent automation to reduce risk and uncover compliance gaps in order to free staff to work at the top of their license.  In this episode, they talk about: What Verisma can do for healthcare organizations Use case examples Some of the risks Verisma mitigates by finding missteps like unauthorized disclosures  AI is taking over the world of informatics Enabling people to work at the top of their license is critical People are not anti-AI, they are anti-opacity A Little About Anupriyo: Anupriyo Chakravarti joined Verisma Systems, Inc. in 2017 as the Senior Vice President of Research and Development. Anupriyo brings 25 years of experience as a highly effective leader in healthcare IT product management and software development for Fortune 500 companies and startups. Anupriyo joined Verisma after serving as vice president of product management and marketing at McKesson, where he led the product management and marketing functions of the Extended Care Services (ECS) business unit. Before McKesson, he worked for 11 years at Surgical Information Systems (SIS), where he led software development, and ultimately product management, to deliver solutions for the surgery and anesthesia departments at health systems and ambulatory surgery centers. Prior to working with SIS, Anupriyo worked for Arthur Andersen, Ryder Dedicated Logistics, IBM and TATA Motors. Anupriyo has a bachelor's degree in mechanical engineering from IIT Roorkee in India.   

DNA tests have become very popular, whether to find long lost relatives, to trace your ethnicity, or maybe to find out some answers about your health – but sometimes the results can bring up more questions than answers...That was certainly the case for Summer McKesson, who joins Andrea to discuss…

Community oncology is playing an increasingly important role in how cancer care is delivered across the United States, with a growing share of patients treated outside large academic medical centers. In this sponsored episode of The Top Line, host Chris Hayden sits down with Kirk Kaminsky, executive vice president and group president of North American Pharmaceutical Services for McKesson, to examine what this shift means for patients, providers and the industry. Kaminsky explains how advances in cancer science have transformed many diagnoses into long-term conditions, increasing the need for accessible, high-quality care in local communities. He discusses the challenges community practices face as innovation accelerates, including evolving reimbursement models, operational pressures and the adoption of new technologies. The conversation also explores the role of community oncology in expanding access to clinical trials and accelerating research, as well as how artificial intelligence is being used to improve both clinical and administrative workflows. Kaminsky shares his outlook on the next five to 10 years of cancer care and why supporting community oncology will be critical to continued progress. Listen to the full interview to learn more.See omnystudio.com/listener for privacy information.

Join us for a special live episode of Independent Insights as we sit down with members of the National Independent Advisory Board (NIAB), at McKesson ideaShare, to explore their vision for the future of pharmacy. Hear firsthand what they've learned from McKesson ideaShare (MiS), what excites them most about the road ahead, and how they're working to elevate the voice of independent pharmacy across the country.HostSuzanne Feeney, PharmDSr. Director, Pharmacy SolutionsMcKesson / Health MartGuestsShelby Knott, PharmDOwnerWarren PharmacyEmmanuel Ayanjoke, PharmDOwnerAltev Community PharmacyGhada Abukuwaik, RPhOwnerCuremed Pharmacy ResourcesTune into Episode 16: Episode 16: Creating Pharmacy's FutureTo listen to APhA President Randy McDonough and Chief Pharmacist Nancy Lyons as they discuss urgent changes and a bold vision for the future of independent pharmacy on this episode of Independent Insights. ReferencesListen to Episode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy.The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

The transition from being a rockstar in your vertical to leading at the C-suite level is one of the hardest jumps in modern business.  Not because you aren't capable, but because the job changes faster than anyone prepares you for, and the timeline to become effective has collapsed from years to months. You used to have a multi-year runway to listen, learn, and settle in. Now the proving ground has accelerated, and you're expected to think enterprise-wide, set direction, shape culture, and operate with conviction almost immediately. And that's where so many leaders get blindsided. They step into the role with deep expertise, strong track records, and every intention of succeeding. But they quickly discover that the behaviors that powered their rise don't automatically translate to the top job.  The stakes are higher, the scrutiny is sharper, and the margin for a slow learning curve is gone. Boards, investors, and teams are already forming judgments before you've even taken your seat. And without realizing it, new executives find themselves operating on outdated instincts in a completely different environment. Bill Koch is a former CEO who now coaches leaders navigating some of the most high-pressure environments. He helps new CEOs compress the transition, build real executive presence, and operate with clarity and confidence. In this episode, we talk about how to accelerate that transition, how to understand how you're actually being perceived, and how to adapt fast enough to avoid losing ground in your first critical months.   You'll also learn: Why the jump from functional mastery to C-suite leadership is so challenging How the timeline for becoming effective has collapsed, and what that means for new executives. The behaviors that helped you rise and why they can quietly derail you in a senior role. How to understand the difference between vertical thinking and enterprise thinking. Why a 360 assessment is often the first real mirror a new executive has ever seen. How boards and teams perceive you long before you think they do Why private equity environments expose leadership weaknesses faster than any other setting. How to cultivate executive presence that signals quiet confidence, not overcompensation. The importance of building a “personal boardroom” to think clearly under pressure.   About the Guest Bill Koch is an executive coach with more than 25 years of C-suite and senior leadership experience across public companies, private enterprises, and private equity–backed firms. A former CEO himself, Bill brings a rare blend of operational depth, boardroom insight, and executive maturity to his coaching practice. His work centers on one mission: helping high performers become highly effective enterprise leaders. For more than a decade, Bill has served as a trusted advisor to CEOs and senior executives navigating high-pressure, high-visibility roles. He coaches leaders across Fortune 500 companies, growth-stage organizations, and academic institutions—guiding them through pivotal transitions, accelerated timelines, and complex leadership challenges. His clients turn to him to gain clarity, sharpen judgment, and build the confident executive presence required to lead at the top. Bill's clients include American Express, Apple, Boeing, Goldman Sachs, John Deere, Mars, MGM, McKesson, Toyota, and others. To learn more, visit https://www.kochleadership.com/ or read Bill's latest insights on Forbes.    About Your Host Craig Picken is an Executive Recruiter, writer, speaker, and ICF Trained Executive Coach. He is focused on recruiting senior-level leadership, sales, and operations executives in the aviation and aerospace industry. His clients include premier OEMs, aircraft operators, leasing/financial organizations, and Maintenance/Repair/Overhaul (MRO) providers, and since 2008, he has personally concluded more than 400 executive-level searches in a variety of disciplines. Craig is the ONLY industry executive recruiter who has professionally flown airplanes, sold airplanes, and successfully run a P&L in the aviation industry. His professional career started with a passion for airplanes. After eight years' experience as a decorated Naval Flight Officer – with more than 100 combat missions, 2,000 hours of flight time, and 325 aircraft carrier landings – Craig sought challenges in business aviation, where he spent more than 7 years in sales with both Gulfstream Aircraft and Bombardier Business Aircraft. Craig is also a sought-after industry speaker who has presented at Corporate Jet Investor, International Aviation Women's Association, and SOCAL Aviation Association.    Subscribe, Rate & Review Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm, so our show reaches more people. Thank you! 

One on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meetingSupport the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USIn this powerful episode of the True Life Podcast, host George Monty delivers a hard-hitting “daily transmission” exposing how corporations and systems deliberately manufacture scarcity to drive profits, control populations, and prevent true abundance from reaching everyday people. Drawing on real-world examples from food, housing, medicine, and more, George reveals the patterns of consolidation, surplus destruction, and artificial shortages that keep society desperate and divided. He calls for recognition, documentation, and rebellion against this “scarcity weapon,” urging listeners to investigate local resources and demand the withheld plenty. This episode is a wake-up call to see beyond the narratives of inflation and supply chain issues to the engineered theft of abundance.Host: George MontyPodcast: True Life PodcastDuration: Approximately 10-15 minutes (based on transcript length)Release Date: Estimated based on content references (late 2025)Listen Here: Explore more episodes and connect with George Monty on the TrueLife platform. Key Timestamps & HighlightsGeorge's monologue flows as a continuous narrative, but we've broken it down into thematic sections with approximate timestamps for easy navigation:•  00:00 - 01:00: The Illusion of Struggle George opens by challenging the narrative that you're failing—it's engineered starvation in abundance. He prompts listeners to check their finances and see how earnings vanish despite higher pay, labeling it “2025's manufactured scarcity” designed for control and extraction.•  01:00 - 02:30: From Ancient Famines to Modern Engineering Contrasting natural famines with today's deliberate hunger, George highlights U.S. food production capacity (enough for 10 billion people) versus 34 million facing food insecurity amid record corporate profits.   He exposes the “machine that weaponizes emptiness.” •  02:30 - 04:00: Food Shortages Exposed•  2024 egg shortage: Not avian flu, but corporate consolidation by Cal-Maine Foods (20% market control), leading to tripled prices and $535 million in profits. •  2022-2024 baby formula crisis: Abbott's monopoly (43% market) caused shutdowns, boosting stock 34% while parents turned to black markets. https://www.theguardian.com/us-news/2025/apr/09/doj-egg-prices-rise-cal-maine-profits•  04:00 - 05:00: Housing and Tech Hoarding•  Housing crisis: 16 million vacant homes in the U.S. versus over 600,000 homeless, as empty properties prove more profitable. •  2025 semiconductor shortage: TSMC's alleged deliberate restrictions via leaked emails to maintain pricing, with chips stockpiled while car prices soar.  (Note: Related to trade secret leaks; broader shortage context available.)https://unitedwaynca.org/blog/vacant-homes-vs-homelessness-by-city/•  05:00 - 06:30: Surplus Destruction and Corporate Mandates George uncovers patterns of destroying goods under USDA/EPA/FDA protocols lobbied by corporations.  He cites the 2024 NASS report (Appendix G, p. 847) on 2.3 billion pounds of produce destroyed to avoid “market destabilization.”  Kroger's 2019 leaked memo advocates “optimal scarcity ratios” for urgency buying. https://www.usda.gov/about-usda/news/press-releases/2023/09/20/usda-expands-efforts-prevent-and-reduce-food-loss-and-wastehttps://www.nass.usda.gov/Charts_and_Maps/Crop_Progress_&_Condition/2024/index.phphttps://www.nationofchange.org/2024/09/03/corporate-greed-exposed-kroger-admits-to-price-gouging-on-milk-and-eggs-amid-antitrust-trial/•  06:30 - 08:00: The Scarcity Playbook Step-by-step breakdown: Consolidate supply, engineer shortages (restrict, destroy surplus), profit from desperation. Blame shifts to weather or labor, not architects.•  08:00 - 10:00: Historical and Ongoing Examples•  2008 housing crisis: Banks held 3.5 million foreclosures as “shadow inventory” to keep prices high. https://en.wikipedia.org/wiki/Subprime_mortgage_crisis•  2020 toilet paper: Procter & Gamble and Georgia-Pacific (55% control) restricted distribution for 300% price surges at 64% capacity. https://www.resourcewise.com/market-watch-blog/are-we-really-running-out-of-toilet-paper-in-the-covid-crisis•  2021 lumber: Weyerhaeuser and West Fraser (40% control) quadrupled prices with underused mills. https://markets.businessinsider.com/news/stocks/lumber-prices-hit-record-highs-soaring-past-year-2021-4-1030299977•  2023 prescription drugs: Wholesalers like McKesson, Cardinal, and AmerisourceBergen (95% control) restrict insulin ($2 production cost) amid shortages. https://www.mmm-online.com/home/channel/drug-shortages-in-america/•  2025 water: Nestlé, Coca-Cola, Pepsi (75% bottled water) amid contaminated public supplies. https://www.grandviewresearch.com/industry-analysis/bottled-water-market•  10:00 - 11:30: Broader Patterns of Waste Amazon destroys 2 million unsold products yearly for scarcity pricing.  Pharma discards effective expired meds.  Energy firms flare gas for 10 million homes.  McKinsey's 2023 report recommends 15-20% below-demand inventory for margins.  Supply chain “disruptions” post-2020? Traffic normalized by Q3 2021, but prices stayed high via throttling. https://www.ethicalconsumer.org/ethical-campaigns-boycotts/amazons-burning-approach-unsold-returned-productshttps://pmc.ncbi.nlm.nih.gov/articles/PMC10834166/

In this episode, host Suzanne Feeney, PharmD, Senior Director, Pharmacy Solutions at McKesson Health Mart and guest Jaime Montuoro, PharmD, Director of Education & Practice Advancement at McKesson Health Mart, unpack two strategies you can deploy now: PGY1 community-based residencies and pharmacy credentialing. You'll learn how residency trained pharmacists can elevate clinical care in workflow, fuel change and help launch billable services. Then, we get practical on credentialing—why becoming “provider ready” matters and how claiming your team's Pharmacy Profiles credentials streamlines payer opportunities. Jaime shares real-world wins, including how Bryant Family Pharmacy partnered with a resident to implement prescriptive authority programs patients were willing to pay for. If you're ready to move beyond the transaction and build sustainable, community anchored care, this playbook will help you start today. HostSuzanne Feeney, PharmDSr. Director, Pharmacy Solutions McKesson / Health MartGuestJaime Montuoro, PharmDDirector, Education and Practice AdvancementMcKesson / Health MartResourcesTune into Episode 11: Maximizing Operations Through Proactive Workflow Health Mart Pharmacies can access Health Mart University (HMU) for:Health Mart pharmacists to claim their CE credit for weekly GameChangers episodesReferencesLearn more about the Health Mart Postgraduate Year One Community-based Pharmacy Residency Program herePharmacy Profiles is a pharmacy-friendly database that allows pharmacy teams to showcase their training and certifications in one place. If you're a Health Mart pharmacy demonstrate your pharmacy's readiness to receive potential patient care opportunities more quickly by having your pharmacy professionals claim their MYPROFILE. Learn more here: my.pharmacyprofiles.com. Pharmacy Profiles is a Strategic Health Alliance II, Inc., vendor.  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In this 200th EPISODE of the Great Trials Podcast, Steve Lowry hosts a detailed discussion with Randy Jordan, an experienced trial lawyer from HunterMaclean in coastal Georgia. The focus is on the complex case of Poppell v. Cardinal Health, McKesson Corporation, and Smith Corporation, which involved 21 plaintiffs and highlighted the opioid crisis.   CASE SUMMARY:  In the case of Poppell, et al, vs McKesson, et al, twenty-one plaintiffs sued three wholesale medicine and medical supply distributors, including McKesson Corporation, Cardinal Health, and J.M. Smith. Under Georgia's Drug Dealer Liability Act, the plaintiffs claimed that the three companies acted as illegal drug dealers in filling orders for opioid medications placed by pharmacies and hospitals in Coastal Georgia. The plaintiffs, mostly children of the addicts, claimed extensive mental and psychological damage resulting from their parents' addictions. (READ MORE)   RANDY JORDAN: He is a uniquely experienced trial attorney, having tried well over one hundred jury cases in state and federal courts across the country. For over thirty years, Randy has defended some of America's largest railroads in a wide array of business and tort matters, including the defense of hundreds of asbestos and other toxic exposure claims. In recent years, Randy has served as lead trial counsel for a major medical supply and distribution company in its opioid litigation. Randy frequently appears in state and federal appellate courts throughout the Southeast and is a frequent speaker on issues relating to the transportation industry. (READ FULL BIO)   CONNECT WITH OUR GUEST: HunterMaclean on X HunterMaclean on LinkedIn HunterMaclean on YouTube HunterMaclean Online   LISTEN TO PREVIOUS EPISODES & MEET THE TEAM: Great Trials Podcast Show Sponsors: Legal Technology Services  Harris Lowry Manton LLP - hlmlawfirm.com Production Team: Dee Daniels Media Podcast Production   Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2

Up first, Inspirogene-by-McKesson with Joe DePinto   InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape. https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/ Our featured interview: Sponsored by MatchRX The TrumpRx Playbook for Independent Pharmacies CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he's not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations. So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter. Connect with MatchRX: MatchRX.com Special Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act" Connect with Greg: https://www.apcinet.com/ Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026. Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/ Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book  https://www.katrinaazer.com/#books   The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx 

Pepe Baynat analiza en Radio Intereconomía la situación general de los mercados. En el plano macro, destaca el buen momento del IBEX 35 en máximos históricos, que continúa con la tendencia alcista que viene marcando este año, mostrando fortaleza frente a otros mercados europeos. En Wall Street, pese a las caídas puntuales del sector tecnológico, el S&P 500 sigue mostrando una estructura sólida y podría volver a testear máximos si mantiene los soportes clave. Pepe Baynat insiste en la importancia de identificar soportes, resistencias y tendencias antes de tomar decisiones, señalando que muchos valores han subido con fuerza y pueden estar en fases de consolidación o corrección. El experto recomienda cautela en acciones que han tenido fuertes revalorizaciones (como Leonardo o McKesson) y advierte del riesgo de “arranques en falso” en compañías que vienen de caídas muy profundas, como Bayer, Stellantis o Nokia, donde pueden darse rebotes técnicos pero con alta volatilidad. Para estrategias de medio y largo plazo, sugiere paciencia en valores castigados pero con potencial de recuperación, como Cellnex, siempre que respeten ciertos niveles técnicos. En otros casos, plantea operaciones de corto plazo muy condicionadas a stops claros. El mercado sigue ofreciendo oportunidades, pero exige disciplina, gestión del riesgo y no dejarse llevar únicamente por subidas recientes o movimientos emocionales.

In this episode of Independent Insights, host Suzanne Feeney sits down with Josh Babb, Senior Director of Government Relations at McKesson, to unpack H.R. 3164, the Ensuring Community Access to Pharmacist Services Act (ECAPS). This bipartisan bill could be a game-changer for independent pharmacies, finally allowing Medicare Part B reimbursement for pharmacist-provided services in states where they're already authorized to deliver care. If you're an independent pharmacist, this episode is a must-listen. You'll hear real stories, understand the legislative landscape, and walk away with clear calls to action, from contacting your legislators to preparing your pharmacy for expanded services. ECAPS isn't just about policy, it's about people, access, and the future of pharmacy.HostSuzanne Feeney, PharmDSr. Director, Pharmacy SolutionsMcKesson / Health MartGuestsJosh BabbSenior Director, Government RelationsMcKessonResourcesHealth Mart University (HMU) for: Helpful CE courses and more on advocacyHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodesAction Items for Listeners:Know Your LegislatorsCheck if your representatives are co-sponsors of H.R. 3164:Find Your Representative & Bill Status Contact Your LegislatorsCall or email your representative.Share personal stories of patient impact and care gaps.Ask for their support or thank them if they're already co-sponsors.Subscribe to Advocacy UpdatesStay informed and get involved through Health Mart's advocacy portal:Health Mart Advocacy Portal Prepare Your PharmacyStart offering eligible services (flue, strep, RSV, COVID-19).Explore billing options (commercial insurance, cash).Get operationally ready for Medicare reimbursement.Host a Legislator VisitInterested in hosting a member of Congress in your pharmacy?Listen to Episode 17: From Aisles to Action: Welcoming Legislators into Your Pharmacy.Reach out to McKesson or Health Mart to get connected.The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Justin Nielsen and Alexis Garcia analyze Monday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

About Lori Logan:Lori Logan is the president and CEO of NASCO, where she leads with a vision to merge innovation with a strong foundation in healthcare. Based in Englewood, Colorado, she brings over two decades of leadership across healthcare's payer, provider, and technology sectors. Known for her curiosity, analytical mindset, and collaborative leadership, Lori has consistently driven growth, transformation, and measurable impact. Her career includes leading multimillion-dollar projects, overseeing teams of hundreds, and managing large-scale integrations and mergers, and acquisitions (M&A) initiatives. Previously, she held senior roles at athenahealth, Geneia, Paladina Health, TriZetto, UnitedHealthcare, Cigna, and McKesson—where she launched groundbreaking products and strategies that improved care coordination and operational efficiency. Recognized for her strategic acumen and results-driven approach, Lori has earned industry accolades, including the TriZetto CEO Pinnacle Award and the Thomson Reuters Healthcare Advantage Award. Her mission remains clear: to reimagine healthcare and create healthier outcomes and lives.Things You'll Learn:Legacy infrastructure hinders scalability; health plans require a modern administrative “chassis” to package benefits, administer payments, and operationalize innovation. This goes well beyond traditional claims systems.Analytics must merge claims, clinical, and engagement data with medical economics precision. Insights then have to reach providers and advocates so care is both effective and reimbursable.A significant amount of value now resides outside of claims in disease management, digital tools, and condition management programs. Members need clear navigation and transparency on what they have, where to go, and what it costs.Provider enablement is essential for value-based care. Success depends on aligned incentives, shared operations, coaching, and trust between plans and providers.Strategic investments should prioritize scalable administration, robust operations, and data pipelines. These foundations let plans attribute value, manage risk, and drive affordability at scale.Resources:Connect with and follow Lori Logan on LinkedIn.Follow NASCO on LinkedIn and explore their website.

In this episode of The Dish on Health IT, host Tony Schueth, CEO of Point-of-Care Partners (POCP), is joined by colleagues Brian Dwyer, POCP's Business Strategy Lead, and Seth Joseph, Managing Director at Summit Health Advisors, to unpack their takeaways from the HLTH25 conference in Las Vegas. Together, they reflect on the energy of the event, the conversations shaping the future of health IT, and interviews recorded live from Podcast Row.The trio kicks off by comparing notes on how HLTH has evolved from a flashy innovation show to something more grounded, a space where serious conversations about interoperability, investment, and operational impact are starting to take hold. Seth notes the event's “coming-of-age” moment, where hype gave way to maturity. Brian agrees, adding that the buzz of startups pitching and investors circling was balanced by a sense of realism about implementation and outcomes.AI dominated every conversation, but with a more pragmatic tone than in years past. The hosts discuss how AI is shifting from novelty to necessity, moving from “AI for AI's sake” to purpose-driven use cases. Interview clips from leaders like Taha Kass-Hout with GE Healthcare spotlight “agentic AI,” where autonomous systems could act as trusted colleagues in care delivery, even participating in tumor board decisions to help extend expertise to rural or underserved regions. The group connects this to the ongoing challenge of ensuring data quality and interoperability as the foundation for any AI success story.Laurie McGraw of Transcarent and Kyle Kiser of Arrive Health bring different but complementary perspectives. Laurie underscores AI's potential to bend the cost curve only if applied safely and effectively, while Kyle highlights the growing complexity of affordability and the need for intelligent systems to help patients and providers navigate fragmented benefits and prescription pricing. Seth and Brian note that the shift toward patient empowerment, fueled by AI and transparency, could signal a broader cultural change in healthcare where consumers wield more influence.The discussion expands into value-based care with insights from McKesson's John Beardsley, who questions whether the industry has truly cracked the code after two decades of running at value-based care and interoperability. John also raises an important tension: small innovators are doing exciting things with AI, but scaling those solutions across full workflows remains the real test. The hosts debate whether new payment models, potentially powered by AI-driven insights, could finally make value-based care viable.Policy and regulation also take center stage as Christopher Chen, MD, MBA, Chief Medical Officer at the Washington State Health Care Authority, shares how state and federal efforts are aligning to accelerate interoperability, reduce provider burden, and modernize prior authorization processes under CMS-0057. The hosts reflect on the importance of federal leadership to align incentives across payers, providers, and technology vendors, echoing lessons learned from the early days of ePrescribing.Other memorable interview moments include John Beardsley's commentary on the CMS Interoperability and Patient App Pledges and how better understanding how NCPDP and FHIR standards bridge pharmacy and clinical data silos could help move the needle. Brian and Seth build on that theme, envisioning a future where agentic AI and patient-facing apps work together to drive true engagement and accountability for health outcomes.In the final stretch, the hosts revisit recurring topics such as physician burnout, administrative burden, and structured data chaos, tying them back to the industry's broader need for smarter implementation and aligned incentives. From Christopher Chen's relaying an anecdote about seeing structured data turned into unreadable images that are faxed in to Arrive Health's use of AI to prevent unnecessary transactions, the episode surfaces a consistent theme: technology alone won't fix healthcare, but when paired with aligned incentives, collaboration, and business transformation, it can finally make measurable progress.The episode closes with optimism. Tony, Brian, and Seth agree that while the system is strained, it's also full of momentum, from maturing AI applications to government action and renewed industry alignment. As Tony puts it, “There's a lot to be hopeful about and a lot of work left to do.”Listen to the full episode to hear interviews from the HLTH25 floor, including thought leaders discussing interoperability, agentic AI, and the real-world changes needed to make healthcare innovation stick.Share The Dish on Health IT from Spotify, Apple Podcasts, or Healthcare NOW Radio, Watch extended clips on the POCP YouTube channel

Miguel Méndez, Analista independiente, comenta su visión sobre un mercado, que cerraba el día de ayer con una venta global de chips, que ha volatilizado 500.000 millones de dólares de capitalización del mercado, ante el aumento del temor por las altas valoraciones de los grandes beneficiados por la IA. ¿Cómo ve Miguel Méndez este selloff? “Es una corrección sana, necesaria, en unas bolsas que esperan resultados empresariales. Comienza a haber rotación de capital de la tecnología a otros sectores. No veo pánico por ningún lado”. En cuanto a valores concretos, el experto financiero destaca varios, que el mismo denomina como “valor caviar”. “Los valores caviar son los que nos han demostrado que históricamente tiene una tendencia alcista muy potente, con buenos resultados, buenos ratios a nivel fundamental” explica. Cencora, Mckesson, Curtiss Wright o Motorola, son algunos de los valores que el analista destaca dentro de esta categoría. “Son valores que puedo tener en la cartera independientemente de que tenga tendencias al alza o a la baja” puntualiza .

It's the Live, Laugh, Larceny Halloween special, and we're celebrating spooky season by getting down and dirty — deep in the bowels of October. This week, Trevin faces a full-blown Halloween dilemma after realizing spiders are the only creature he likes less when they have a big butt. Because, really — anything that plump and poisonous can't be trusted. Meanwhile, Amanda's questioning her life choices after watching the Is It Cake? Halloween special and realizing that hobbyists are somehow better at everything than she is. Our game this week is a frightful All Hallow's Eve edition of This or That, where Amanda forces Trevin to choose between the true terrors of October: slasher films or psychological horror? Cute or scary costumes? Carve or paint your pumpkins? Foggy nights or full moons? Scream franchise or Halloween classics? We're tackling every haunted dilemma that defines the season. For storytime, Amanda shares the eerie tale of Shannon Dennis and Tina Jamarillo of Barstow, California — two women who let the Halloween spirit possess them a little too much. After police receive reports of a dead body in the desert, these grown adults might just end up looking like real dummies. Trevin's story opens with a nomination for the scariest Halloween costume ever: a suit. In a chillingly relatable tale of corporate America, capitalism, and existential dread, meet Bo Whitener, a Georgia man working for McKesson's pharmaceutical distribution center. When a massive CEO pension check lands in the wrong hands, Bo decides to dress up as the big boss himself for the company Halloween party — a move that might earn him a police call, a suspension, or a long interrogation by a middle manager. Beyond the usual Halloween tropes, today's episode ties together Spirit Halloween, candy corn, and — most importantly — bowels. Put on your waterproof boots and light your jack-o'-lanterns, because this true petty crime and comedy podcast special dives deep — uncomfortably deep — into the bowels of spooky season. Join our Facebook Group: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/groups/livelaughlarcenydoomedcrew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For ad-free episodes and lots of other bonus content, join our Patreon! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.patreon.com/LiveLaughLarceny⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Check out our website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you have a crime you'd like to hear on our show OR have a personal petty story, email us at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠livelaughlarceny@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or send us a DM on any of our socials! Learn more about your ad choices. Visit podcastchoices.com/adchoices

HLI Partners co-founders Joe Hills and Josh Lipoff share how they built a boutique CRE firm, Orlando industrial/office trends, and strategies to win deals.The Crexi Podcast connects CRE professionals with industry insights built for smart decision-making. In each episode, we explore the latest trends, innovations and opportunities shaping commercial real estate, because we believe knowledge should move at the speed of ambition and every conversation should empower professionals to act with greater clarity and confidence.  In this episode of The Crexi Podcast, Shanti Ryle sits with Joe Hills and Josh Lipoff to discuss their transitions from major firms to launching their own company, competitive strategies, and the intricacies of the Central Florida market. Hills and Lipoff share insights into their career paths, the importance of mentorship, and the creative solutions they employ to meet tenant needs. They also highlight market trends, investment strategies, and the challenges and opportunities in Orlando's evolving CRE landscape.Meet Joe Hills and Josh Lipoff: Founders of HLI PartnersCareer Beginnings in Commercial Real EstateEarly Challenges and MentorshipForming a Strong PartnershipLaunching HLI PartnersStrategies for Success in CRENavigating Market ChallengesCurrent Trends in Central Florida's Industrial MarketSpecialty Tenants and Market DynamicsImpact of COVID-19 on Home BuildingShifts in Industrial Space DemandBuild-to-Suit and Infill PricingMacro Factors Influencing Orlando's MarketOpportunities and Risks in Orlando's MarketRapid Fire Questions and AdviceFinal Insights and Parting Words About Joe Hills:Over the course of his career, Joe Hills has been involved in over 475 deals, closing more than 1 billion dollars in transaction volume. In 2020, Joe played a key role in the new location of a 119,684 s.f. building for Paradise Grilling System. Thereafter in 2021, Joe assisted in the building of an additional 200,000 s.f. warehouse space for Signature Brands as well as the renewal of Samsung's current lease for their 550,000 s.f. space. With an extensive track record in the industrial sector, Joe has developed a strategic orientation towards areas of manufacturing. In the span of his 15-year career in commercial real estate, Joe has successfully leased and sold more than twenty-five million square feet of space with transactions totaling more than $1 billion. About Josh Lipoff:Josh Lipoff brings over 20 years of corporate business development and has successfully negotiated several million square feet of Central Florida's Industrial team transactions. Prior to joining HLI Partners, Josh spent 12 years with JLL's Industrial team in Orlando. During his career, Josh specialized in Tenant Representation, build-to-suit and site selection, financial analysis, and lease and contract evaluation. National clients served over the years have included: Brookfield Properties, Stonemont, McKesson, Ocean Spray, Walgreens, Mattress Firm, Sysco, Freeman, Iron Mountain, United Stationers, and Kellogg's. For show notes, past guests, and more CRE content, please check out Crexi's blog.Looking to stay ahead in commercial real estate? Visit Crexi to explore properties, analyze markets, and connect with opportunities nationwide. Follow Crexi:https://www.crexi.com/​ https://www.crexi.com/instagram​ https://www.crexi.com/facebook​ https://www.crexi.com/twitter​ https://www.crexi.com/linkedin​ https://www.youtube.com/crexi

Investor Nancy Brown joins us at Aspen Ideas Health to share her blueprint for impactful investments. Identify public health breakthroughs that deliver measurable cost and quality improvements — then show how they can thrive in the marketplace. You don't have to look far to see this playbook in action. One of the year's biggest health exits, Omada Health, is a digital version of the CDC's Diabetes Prevention Program. At Oak HC/FT, Nancy has partnered with entrepreneurs who are redefining how America stays healthy — and she's eager to see more people with public health roots take the leap into building impactful companies.Please note: this conversation happened before HR1 was passed, so big Medicaid cuts were a threat but not yet a reality when we spoke.In this episode, we discuss:Lessons from Todd Park in the early days of athenahealthHow to turn good ideas into great businessesNancy's advice in an era of policy disruption: keep on building and proving valueThe lesson Kaiser Permanente is still teaching usNancy reminds us that in reality, even a brilliant idea needs to have ROI built in:“We look for entrepreneurs, for innovators, who have really defined a way in which to find a cohort of patients, it could be pregnant Medicaid moms... And they have identified if they apply a certain clinical process consistently to that population, they will get a consistently good outcome, quality outcome, and they can do it in a sustainable [way] at a sustainable price.”Relevant LinksRead Oak HC/FT's AI Investment PolicyExplore businesses Nancy mentioned from Oak HC/FT's investment portfolio:Maven ClinicOshi Health About Our GuestNancy Brown is a General Partner at Oak HC/FT, a leading venture and growth equity firm investing in transformative healthcare and fintech companies. Since joining Oak HC/FT at its inception in 2014, Ms. Brown has focused on identifying and supporting technology-enabled healthcare services that deliver measurable clinical and financial impact. She focuses on growth equity and early-stage venture investments in healthcare, serving on the boards of innovative companies such as Firefly Health, Groups Recover Together, InterWell Health, Maven Clinic, Oshi Health, Regard, Unite Us, and Wayspring. Her portfolio also includes Noom, TurningPoint Healthcare Solutions, Limeade (ASX: LME), OncoHealth, and OODA Health.Ms. Brown brings over three decades of operational and leadership experience to her investment role. Prior to Oak HC/FT, she was Vice President of Strategy and Business Development at McKesson Technology Solutions and Chief Growth Officer at MedVentive (acquired by McKesson in 2012). Previously, she served as Senior Vice President of Clinical Services and Corporate Development at athenahealth, and earlier held senior roles at McKesson and Harvard Community Health Plan. She also co-founded Abaton.com, one of the first web-based clinical solution companies, which was later acquired by McKesson.A graduate of the University of New Hampshire (B.S. in Zoology) and Northeastern University (MBA), Ms. Brown is an active mentor and advisor. She serves on Northeastern's D'Amore‑McKim School of Business Dean's Executive Council and is involved in the Roux Institute's Future of Healthcare Founder Residency program.

Under the Inflation Reduction Act (IRA), government-negotiated drug prices for high Medicare spend drugs will take effect on January 1, 2026. Pharmacies must enroll with the CMS Medicare Transaction Facilitator (MTF) to receive manufacturer refunds when the acquisition cost exceeds the Maximum Fair Price (MFP). Without enrollment, they may be excluded from the program.In this episode, we break down the critical steps pharmacies must take to enroll in the CMS MTF ahead of January 1, 2026. With manufacturer refunds hinging on proper enrollment, we explore the six-part form, key financial selections, and the role of third-party entities. We also spotlight the urgency of completing the enrollment by November 15, 2025, to avoid delays in reimbursement, for those wishing to participate in MTF. HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson / Health MartGuestsEmily FlaugherVice President and General Manager of Payer SolutionsMcKesson / Health Mart AtlasResources Pharmacy Toolkit on Medicare Transaction Facilitator AvailableCMS has released a pharmacy toolkit on the Medicare Transaction Facilitator (MTF) as part of the Medicare Drug Price Negotiation Program (MDPNP). The toolkit provides important information and step-by-step instructions for enrolling your pharmacy in the MTF Data Module. Additional pharmacy and dispensing entity resources are available here. As a reminder, implementation of the MDPNP will begin on January 1, 2026; pharmacies will still be able to enroll after this date.References Helpful CMS.gov Resources: Pharmacy and Dispensing Entity Resources | CMSSelected Drugs and Negotiated Prices | CMSThe views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy. Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/  First, #TWIRx News - the FDA approves Inluriyo imlunestrant on 9/25/2025 which is to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025)  Second, Nested-Knowledge - is going to revolutionize information access and leverage. This is a powerful tool with evidence synthesis tools for medical researchers. This will help accelerate, collaborate, automate and share the latest and personalized treatment plans. (https://nested-knowledge.com/) Next, announcing "Evidence based Podcasting", the new standard in audio learning for Providers and next level in podcast Continuing Medical Education (CME). (https://pharmacypodcast.com/2025/09/26/evidence-based-podcasting-and-the-future-of-medical-education/ ) Shout out to Nick Calla with Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for PALSONIFY™ (paltusotine), a nonpeptide, selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist. (https://www.wvnews.com/news/around_the_web/partners/pr_newswire/subject/licensing_marketing_agreements/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine/article_9b42bfe7-69a6-58be-98ff-5e2245145415.html) Today we have two guest Pharmacists to dig into the "Trust in Healthcare" theme of today's #TWIRx -- the godfather of Functional Pharmacy Robert Kress RPh., and Dr. Lauren Castle, PharmD, MS, AFMC - Founder & CEO of Functional Medicine Pharmacists Alliance. Who do you trust? What information is trustworthy and why?  Our special feature is updates on 'Cell & Gene Therapy' with McKesson's Head of Cell Gene Advanced Therapies, Joe DePinto at InspiroGene!  (https://inspirogene.com/)  Today's TWIRx is sponsored by 'Sykes & Company' the Pharmacy Accounting Jedi Masters and Independent Pharmacy Cooperative (IPC) and how they're revolutionzing digital health and new revenues with the iCare+ System!    Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx

Ever wondered what it's really like to invite and host a legislator at your Pharmacy?In this episode of Independent Insights, we sit down with Shannon Tesini, a Certified Pharmacy Technician and passionate pharmacy advocate, to demystify the process of preparing for a legislative visit. Whether you're a technician, pharmacist, or pharmacy owner, Shannon shares what it takes to confidently represent your profession and your patients at the policy level.You'll learn:What to expect before, during, and after a legislative meetingHow to prepare your message and make it personal and powerfulTips for staying calm, clear, and confident—even if it's your first timeWhy advocacy isn't just for pharmacists—and how technicians can lead the chargeIf you've ever thought, “I care, but I don't know where to start,” this episode is your roadmap to becoming a pharmacy advocate who makes a difference.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsShannon Tesini, CPhT Pharmacy TechnicianMcNabb PharmacyResourcesTune into Episode 16: Creating Pharmacy's Future where APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Health Mart Pharmacies can access Health Mart University (HMU) for:  Helpful CE courses and more on pharmacy advocacyHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

Donate (no account necessary) | Subscribe (account required) Join Bryan Dean Wright, former CIA Operations Officer, as he dives into today's top stories shaping America and the world. In this episode of The Wright Report, we cover the shocking assassination of Charlie Kirk, Russian drones breaching NATO airspace, Trump's war on Venezuela's cartels, Mexico's tariff fight with China, a pharmaceutical victory in Tennessee, and new revelations in the 9/11 families' lawsuit against Saudi Arabia. From political violence at home to dangerous escalations abroad, today's brief carries heavy news on a day of prayer and remembrance.   Charlie Kirk Assassinated in Utah: The 31-year-old Turning Point USA founder was gunned down while speaking at Utah Valley University. President Trump called him “a martyr for truth and freedom” and ordered flags at half-staff. Video shows a sniper shot to the neck from a rooftop as Kirk addressed thousands of students. MSNBC sparked outrage with coverage that suggested Kirk's “awful words” made his death inevitable. Bryan warns, “The seal has now been broken: if you make those arguments or say those words, you're fair game too.”   Russian Drones Violate Polish Airspace: NATO confirms 19 Russian drones flew over 150 miles into Poland, with several shot down by Dutch and Polish jets. Bryan cautions that even an accident could spark a “Gulf of Tonkin–like incident” dragging NATO into direct war with Moscow.   Trump Escalates War on Venezuela's Cartels: After U.S. forces sank a drug boat killing 11, critics accuse Trump of overstepping presidential authority. War Secretary Pete Hegseth countered: “This strike sent a clear message: If you traffic drugs toward our shores, the United States military will stop you cold.”   Mexico Tariffs Chinese Imports: President Claudia Sheinbaum hikes tariffs on Chinese cars and textiles to 50 percent, aiming to shield Mexican workers and appease Trump's demands to close tariff loopholes. Bryan notes this could undercut Beijing's backdoor into U.S. markets.   Saving U.S. Antibiotics in Tennessee: Trump brokers a deal forcing Walmart and McKesson to buy amoxicillin from Bristol, Tennessee, rescuing America's last antibiotic factory from collapse. “Don't bet against America,” Bryan says, “because with leadership that actually loves this country, we will win.”   9/11 Families' Lawsuit Against Saudi Arabia Advances: A New York judge allows families to pursue claims that Saudi intel officers Omar al-Bayoumi and Fahad al-Thumairy aided hijackers. ProPublica reports al-Bayoumi was a Saudi intel asset in the U.S. coordinating with the GIP. Bryan calls for Trump to declassify CIA files: “It's time for some sunlight on what did or didn't happen that horrific day.”   "And you shall know the truth, and the truth shall make you free." - John 8:32     Take your personal data back with Incogni! Get 60% off an annual plan at incogni.com/TWR and use code TWR at checkout.     Keywords: Charlie Kirk assassination Utah, Trump martyr for truth, MSNBC Charlie Kirk coverage, Russian drones Poland NATO, Trump Venezuela drug cartels strike, Pete Hegseth drug cartels al Qaeda, Mexico tariffs Chinese imports Sheinbaum, Trump tariff war China backdoor, U.S. antibiotics Bristol Tennessee amoxicillin, Walmart McKesson Trump drug deal, 9/11 families lawsuit Saudi Arabia, Omar al-Bayoumi Saudi intel, Fahad al-Thumairy Saudi cleric, CIA Saudi 9/11 declassification

With a career background that has included stops at medical supply and equipment behemoth, McKesson, as well as executive roles at a variety of life sciences companies, Botanical Sciences CEO Gary Long knows healthcare. While his background may not seem like a traditional fit for the medical and hemp-derived cannabis world, his arrival along with other outsiders signal a transformation underway in a category becoming known more for its positive lifestyle impacts than for previous negative stereotypes.In our conversation we talk about what led him to the industry, what he sees as opportunities and threats, and how cannabis has slowly become part of the growing health and wellness movement that continues to unfold across the country.Mentioned in this episode:Botanical SciencesONE59Traktion Talks PodcastSpecial thanks to Go Brewing / Easy Man for being a show sponsor! Use code NATION15 at checkout for either brand to get 15% off your order.We'd love your feedback!

Join hosts Luke Carignan and Bo Brabo for a lively episode of The ASHHRA Podcast, where they chat with Victor Gaines, AVP of Talent Acquisition at Wellstar Health System. Kicking off with NFL banter and a playful scoop on Taylor Swift and Travis Kelce's "engagement" (spoiler: it's all in good fun), the conversation quickly dives into Victor's eclectic career journey—from finance and TV to healthcare, pizza at Papa John's, and bourbon at Sazerac—now circling back to innovative TA in healthcare.Victor shares how his cross-industry experience (spanning high-volume hiring at Comcast and Papa John's to specialized roles at Fiserv and McKesson) equips him to tackle post-pandemic challenges like agility, digital transformation, and operational efficiency. The trio explores the transformative power of AI in TA: from automating scheduling and screening to combating bias and "hallucinations." Thought-provoking questions arise—can AI eradicate human biases, or does it amplify them? How close are we to AI-driven individualized learning or even clinical efficiencies?Key takeaways:Diverse Backgrounds Fuel Innovation: Victor's non-traditional path highlights why healthcare is increasingly recruiting external talent for fresh perspectives.AI's Double-Edged Sword: Essential for high-volume tasks but demands a "human in the loop" to mitigate risks like unintended bias or outdated data.Future-Proofing TA: Insights on pre-boarding, ambient listening in clinics, and ethical AI use—could we see 30%+ efficiency gains in five years?Victor's wisdom: "We've seen unprecedented change; now it's about agility to persevere." Whether you're in HR, TA, or curious about AI's role in work, this episode sparks debate on balancing tech with human judgment.Tune in on your favorite podcast platform or visit ashhra.org/ashhra-podcast. What biases lurk in your processes? Share your thoughts!From Our Sponsors...Optimize Pharmacy Benefits with RxBenefitsElevate your employee benefits while managing costs. Did you know hospital employees fill 25% more prescriptions annually than other industries? Ensure cost-effective, high-quality pharmacy plans by leveraging your hospital's own pharmacies. Discover smarter strategies with RxBenefits.Learn More here - https://rxbene.fit/3ZaurZNStreamline HR Compliance with oneBADGEhealthcareSimplify screening, credentialing, and compliance for healthcare HR. oneBADGEhealthcare from ISB Global offers a tailored solution to keep your workforce compliant and efficient. Built for healthcare leaders, it's your all-in-one compliance tool.Get Started here - https://isbglobalservices.com/onebadgeunitedstates/ashhra/ Support the show

The Future Is Now: APhA President Randy McDonough on Leading Change in Independent PharmacyWhat does the future of independent pharmacy look like—and how do we get there?In this powerful episode of Independent Insights, APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Randy shares his frontline perspective as both a national leader and a practicing owner.Whether you're a pharmacist, technician, or pharmacy owner, this episode will leave you inspired, informed, and ready to take action. Tune in and be part of the movement to redefine the role—and the value—of independent pharmacy in healthcare.HostSuzanne Feeney, PharmDSenior Director, Pharmacy SolutionsMcKesson/ Health MartGuestsRandy McDonough, PharmD, MS, BCGP, BCPS, FAPhAPresident, American Pharmacists Association (APhA) and Health Mart Pharmacy OwnerNancy Lyons, BSPharm, MBA, CDCESVice President, Chief Pharmacy OfficerMcKesson/ Health MartResourcesHealth Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses, advanced trainings, and more Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

In today's episode, host Edward Wagoner sits down with Drew DePriest, Director of Real Estate OT at McKesson and recently named one of IFMA's top global influencers in facility management. Drew discusses the importance of mental health for facility management professionals, his own journey with it, and the importance of creating an environment where discussing mental well-being is normalized. The conversation also touches on how technology and AI influence FM as well as answering a few rapid-fire questions from listeners.Sponsor:This episode is sponsored by ODP Business Solutions! Connect with Us:LinkedIn: https://www.linkedin.com/company/ifmaFacebook: https://www.facebook.com/InternationalFacilityManagementAssociation/Twitter: https://twitter.com/IFMAInstagram: https://www.instagram.com/ifma_hq/YouTube: https://youtube.com/ifmaglobalVisit us at https://ifma.org

Welcome to PART ONE of our Three Part series covering the McKesson IdeaShare Conference in Nashville TN.   Today's interviews features: Ashton Maaraba President of IPC Digital Health Independent Pharmacy Cooperative (IPC)   U.S. Representative Buddy Carter Georgia State Congress   Greg Reybold Vice President of Healthcare Policy & General Counsel APCI, Inc.   Christopher Darling Darling Apothecary LLC   Chuck Schneider Lifecykel

As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company's mission of improving healthcare in every setting. Learn how she's working to connect the healthcare ecosystem to bring additional access and benefits to patients. Highlights include:Her view of the opportunities for collaboration to build a better healthcare value chainDiscussion of how we can improve the patient's experienceAreas where she sees the most potential for innovation across healthcare

What if the key to boosting your pharmacy's revenue—and your community impact—was already within your four walls?In this episode of Independent Insights, host Suzanne Feeney sits down with Alex Anderson, sixth-generation owner of Oswald's Pharmacy, to explore how he transformed a single lift chair into a thriving front-end and DME (Durable Medical Equipment) business that now spans 5,000+ square feet and drives significant revenue.Whether you're a one-person show or managing a full team, this episode is packed with practical, scalable strategies to help you:Start small and smart with DME—even with limited space or staffIdentify top-performing front-end products that meet real community needsUse rentals to generate recurring revenue with minimal investmentLeverage your team's hidden talents to grow marketing and outreachDrive foot traffic with smart merchandising, local partnerships, and online visibilityYou'll also hear how Alex uses inventory as a strategic tool—not just a shelf filler—to create a one-stop shop that keeps customers coming back. If you've ever wondered how to diversify your revenue, better serve your patients, and make your front-end work harder for your business, this is the episode you can't afford to miss.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson/Health MartGuestsAlex AndersonOwnerOswald's PharmacyResourcesTune into Independent Insights Episode 12: The Power of Partnerships Health Mart Pharmacies can access Health Mart University (HMU) for:Helpful CE and non-CE courses and more on front-end  Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

How do you lead organizational transformation when AI is moving faster than your roadmap can keep up?   Carlie Bissler, a product leader at McKesson, breaks down what it takes to guide large enterprises through change in the age of AI. From building trust and authenticity as a leader to shifting from "change management" to "change leadership," Carlie shares pragmatic advice for preparing your teams — and yourself — for the unknown.   She also gets real about fear in the workplace, the shame some still feel about using AI tools, and why the best CX transformations start on the inside. If you're navigating the messy middle of enterprise innovation, this episode is your blueprint for embracing agility, empowering your people, and staying human in an increasingly automated world. Key Moments:   00:00 Change Leadership, Innovation, and AI04:46 Who is Carlie Bislser of McKesson?06:13 The Role of Psychology in Leadership14:20 Navigating Organizational Transformation18:33 Embracing AI and Building Trust29:12 The Growing Fear of AI in the Workplace34:32 The Shift from AI as a Cost Center to an Asset38:03 Mentorship and Community43:13 Preparing for AI-Driven Transformation45:43 The Human Touch in Customer Experience50:57 Lightning Round: Quick Insights & Advice –Are your teams facing growing demands? Join CX leaders transforming their AI strategy with Agentforce. Start achieving your ambitious goals. Visit salesforce.com/agentforce Mission.org is a media studio producing content alongside world-class clients. Learn more at mission.org

Joe DePinto, MBA, Head of Cell, Gene & Advanced Therapies at McKesson, joins the show to discuss InspiroGene, McKesson's end-to-end platform built to address the complex delivery, coordination, and commercialization needs of cell and gene therapies. He breaks down how InspiroGene integrates logistics, specialty pharmacy, patient support services, and real-time data tracking to close critical gaps in the CGT ecosystem—especially around why many eligible patients are still not being identified, referred, or treated. He also explores the broader vision: enabling scalable access to these therapies as they move from rare diseases to larger populations, and what it will take—from providers, payers, and pharma—to meet that future. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Doug & Dan are getting ready to head to the Big Apple on this week's episode of The Hype! But before they get set for Fanatics Fest 2025, the guys react to the surprising move that sent Red Sox slugger Rafael Devers to the Giants and breifly take a look at his Bowman market. Plus the guys discuss if Shohei's return to the mound be a good or bad thing for his career & collectibility and preview all the events going down at this year's Fanatics Fest in New York. Then Cody talks to Topps sketch card artist Ian McKesson about his recent work in Topps Series 2 Baseball and how it feels to have his work featured in upcoming Disney sets. Plus Ian takes us behind the scenes to show how he chooses what subjects to sketch and gives us a look at some of his exclusive artist proof cards! Watch this episode on our Mojobreak Media YouTube channel! Check out box breaks, interviews and more on our Mojobreak Media YouTube channel and subscribe today. Go to Mojobreak.com to get a spot in breaks of 2025 Topps Chrome Marvel & more! Visit our shop in Santa Clara or order online at mojobreakshop.com